文献速递肿瘤 PET/CT

高分辨率专用乳腺18F-FDG PET图像的纹理分析与乳腺癌免疫组化因子及亚型相关

Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-09-21

本研究纳入127例连续患者的139个乳腺肿瘤,治疗前行专用乳腺18F-FDG PET扫描,提取常规代谢参数及5个纹理特征。结果显示10个分析特征中9个与免疫组化亚型显著相关,HER2阳性肿瘤摄取更高且异质性不同,专用乳腺PET较全身PET分类能力整体提升。

要点

  • 10个PET特征中9个与免疫组化亚型显著相关。
  • HER2阳性肿瘤摄取显著更高(p<0.001,AUC>0.70)。
  • 专用乳腺PET较全身PET对免疫组化因子和亚型的分类能力整体提升。

核心结论

  • 高分辨率专用乳腺PET图像提取的参数与乳腺癌免疫组化因子及亚型呈现新的更强相关,优于全身PET。

研究设计与样本

  • 纳入127例连续患者的139个乳腺肿瘤,治疗前均行18F-FDG PET扫描,提取SUVmax、SUVmean、代谢活跃肿瘤体积(MATV)、总病灶糖酵解(TLG)及5个纹理特征,采用非参数假设检验分析关联。

主要发现

  • HER2阳性肿瘤摄取显著更高(p<0.001,AUC>0.70),整体和区域异质性不同(p=0.002、p=0.016,AUC<0.70)。
  • 10个分析特征中9个与免疫组化亚型显著相关。
  • 管腔A样(LA)肿瘤摄取较低(p<0.001),各亚组比较AUC为0.71至0.88。
  • LA与管腔B样/HER2-(LB-)比较时异质性指标显著相关(p<0.01),区域异质性指标比SUV更具鉴别力(AUC=0.80 vs AUC=0.71)。
  • LB+和HER2阳性非管腔(HER2pnl)肿瘤较LA肿瘤显示更多区域异质性(AUC分别为0.79和0.84)。

关键数值与推荐

  • 免疫组化分为5个亚型:管腔A样(LA)、管腔B样/HER2-(LB-)、管腔B样/HER2+(LB+)、HER2阳性非管腔(HER2pnl)、三阴性(TN)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to determine whether PET textural features measured with a new dedicated breast PET scanner reflect biological characteristics of breast tumors. METHODS: One hundred and thirty-nine breast tumors from 127 consecutive patients were included in this analysis. All of them underwent a 18F-FDG PET scan before treatment. Well-known PET quantitative parameters such as SUV m a x , SUV m e a n , metabolically active tumor volume (MATV) and total lesion glycolysis (TLG) were extracted. Together with these parameters, local, regional, and global heterogeneity descriptors, which included five textural features (TF), were computed. Immunohistochemical classification of breast cancer considered five subtypes: luminal A like (LA), luminal B like/HER2 - (LB -), luminal B like/HER2+ (LB+), HER2-positive-non-luminal (HER2pnl), and triple negative (TN). Associations between PET features and tumor characteristics were assessed using non-parametric hypothesis tests. RESULTS: Along with well-established associations, new correlations were found. HER2-positive tumors had significantly higher uptake (p < 0.001, AUCs > 0.70) and presented different global and regional heterogeneity (p = 0.002, p = 0.016, respectively, AUCs < 0.70). Nine out of ten analyzed features were significantly associated with immunohistochemical subtype. Uptake was lower for LA tumors (p < 0.001) with AUCs ranging from 0.71 to 0.88 for each subgroup comparison. Heterogeneity metrics were significantly associated when comparing LA and LB - (p < 0.01), being regional heterogeneity metrics more discriminative than any other parameter (AUC = 0.80 compared to AUC = 0.71 for SUV). LB+ and HER2pnl tumors also showed more regional heterogeneity than LA tumors (AUCs = 0.79 and 0.84, respectively). After comparison with whole-body PET studies, we observed an overall improvement in the classification ability of both non-heterogeneity metrics and textural features. CONCLUSIONS: PET parameters extracted from high-resolution dedicated breast PET images showed new and stronger correlations with immunohistochemical factors and immunohistochemical subtype of breast cancer compared to whole-body PET.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Moscoso A, Ruibal Á, Domínguez-Prado I, et al. Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer. Eur J Nucl Med Mol Imaging. 2017. PMID: 28936601. doi:10.1007/s00259-017-3830-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。